Nacionalinis vezio institutas

Vilnius 08660

0 studies enrolling now · 2 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed
• Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) — Running, not enrolling